Rare diseases
Investigational molecules
Locations
Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
The NetherlandsStudy of Latozinemab for Patients with Neurodegenerative Diseases Who Previously Participated in a Latozinemab Study
The NetherlandsStudy of emactuzumab compared to placebo in patients with tenosynovial giant cell tumor
The NetherlandsStudy of Nivolumab and Ipilimumab for Patients with Type B3 Thymoma and Thymic Carcinoma After Chemotherapy
The NetherlandsStudy on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol
The NetherlandsStudy of Inhaled Pirfenidone for Patients with Progressive Pulmonary Fibrosis
The NetherlandsStudy on the Effectiveness of Relatlimab, Ipilimumab, and Nivolumab in Patients with High-Risk Clear Cell Renal Cell Cancer
The NetherlandsStudy of Belantamab Mafodotin for Patients with Relapsed or Refractory AL Amyloidosis
The NetherlandsStudy Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement
The NetherlandsStudy of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)
The NetherlandsStudy on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis
The NetherlandsStudy on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
